In conclusion, the current study provided the first comprehensive pan cancer profile of BRIP1 abnormal expression, methylation, alteration, and their therapeutic and prognostic implications, covering 10,967 tumor samples across 32 cancer types. This evidence concerns the gene BRIP1 and neoplasm.